News and Announcements
CRIISP Information Session webinar recording & June special offer for first-time users
- Published June 12, 2019 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Hear from Wholesale Investor’s MD, Steve Torso, on our new, end-to-end, SaaS platform for raising capital and investment. Steve will take you through a demo of CRIISP including its features and growth opportunities.
CRIISP Special Offer for June
For the month of June, new users that sign up to CRIISP will pay the standard price of $2,400+GST and receive the below additions as complimentary.
- 12-month access to the platform
- Full DD Folder set up
- FAQ set up
- Data and Analytics
- Digital tracking of transaction and digital signatures for the share application
- Posting in the CRIISP Investor Marketplace
- Publishing on WI – Listing and significant news
- Email newsletter promotion
There are less than three weeks to activate this offer, so please email [email protected] for more information on how to access this opportunity.
Company Updates
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer
In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts
As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.
Backed By Leading Investment Groups and Family Offices
